The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer

Published:2016-08-24 Issue:9 Volume:16 Page:911-918
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Wilson James M.,Parker Christopher

Funder

National Institute for Health Research Royal Marsden and Institute for Cancer Research Biomedical Research Centre

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/14737140.2016.1222273

Reference39 articles.

1. Global cancer statistics, 2012

2. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

3. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

4. Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)

5. Metastasis to bone: causes, consequences and therapeutic opportunities

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Micellar solution of [223Ra]RaCl2: Reaching renal excretion, potent efficacy in osteoblastic osteosarcoma in PDX model, biochemistry alterations and pharmacokinetics;International Journal of Pharmaceutics;2024-03

2. Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer;Cancers;2024-02-22

3. The Bone Pathway: 223Ra-Dichloride;Radiopharmaceuticals;2024

4. Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model;International Journal of Molecular Sciences;2023-01-22

5. Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation;Journal of Geriatric Oncology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3